Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNSS | AMGN | VRTX | BMY | GILD |
| Company | Sunesis Pharmaceutic | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 16.35 | 268.92 | 423.41 | 55.84 | 92.26 |
| High | 24.80 | 270.31 | 424.58 | 56.42 | 93.07 |
| Low | 16.35 | 267.15 | 415.15 | 55.08 | 90.82 |
| Last | 18.62 | 269.43 | 416.96 | 56.38 | 91.65 |
| Change | +3.64 | +0.49 | -7.30 | +0.47 | -0.73 |
| % Change | +24.30% | +0.18% | -1.72% | +0.84% | -0.79% |
| Volume | 20,069,086 | 2,684,500 | 1,226,000 | 9,060,899 | 8,955,300 |
| 20-Day Average Volume | 6,608,405 | 3,582,535 | 2,074,325 | 10,988,220 | 6,584,240 |
| Previous Close | 14.98 | 268.94 | 424.26 | 55.91 | 92.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.35 | 263.34 | 412.86 | 56.75 | 91.83 |
| 20-Day Raw Stochastic | 62.71% | 82.64% | 40.60% | 42.03% | 51.51% |
| 20-Day Relative Strength | 78.29% | 45.84% | 43.40% | 49.16% | 51.41% |
| Weighted Alpha | +200.53 | -15.51 | -8.82 | +17.85 | +15.02 |
| Today's Opinion | 88% Buy | 88% Sell | 72% Sell | 40% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 72% Sell | 40% Buy | 88% Buy |
| Last Month's Opinion | 40% Buy | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +35.37% since 02/17/21 | +1.98% since 01/08/25 | +1.18% since 01/08/25 | -0.76% since 01/08/25 | +2.82% since 01/08/25 |
| Low | 3.53 on 02/22/21 | 260.55 on 01/10/25 | 397.24 on 01/13/25 | 54.81 on 01/13/25 | 88.57 on 01/10/25 |
| High | 7.09 on 02/24/21 | 272.82 on 01/15/25 | 425.49 on 01/15/25 | 56.74 on 01/15/25 | 93.07 on 01/16/25 |
| 1-Month | |||||
| %Chg | +75.58% since 01/22/21 | +1.10% since 12/16/24 | -10.92% since 12/16/24 | +0.91% since 12/16/24 | -0.43% since 12/16/24 |
| Low | 2.35 on 01/28/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 54.81 on 01/13/25 | 88.57 on 01/10/25 |
| High | 7.09 on 02/24/21 | 272.82 on 01/15/25 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | +291.18% since 11/24/20 | -16.23% since 10/16/24 | -14.43% since 10/16/24 | +5.64% since 10/16/24 | +5.65% since 10/16/24 |
| Low | 1.33 on 11/25/20 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 7.09 on 02/24/21 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +92.27% since 08/24/20 | -19.12% since 07/16/24 | -14.73% since 07/16/24 | +36.84% since 07/16/24 | +27.93% since 07/16/24 |
| Low | 1.12 on 11/06/20 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 41.20 on 07/17/24 | 70.78 on 07/23/24 |
| High | 7.09 on 02/24/21 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,255 | 144,827,520 | 107,379,288 | 114,348,624 | 114,220,280 |
| Shares Outstanding, K | 18,093 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 2,070,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -23,330,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.21 | 0.56 | 0.40 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/09/21 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.620 on 01/03/25 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.99 | 0.00 | 47.79 | 20.85 |